Top Markets
#1 Merlin's Seal BTC Merlin's Seal BTC +41.73%
#2 Pons Pons +31.17%
#3 Zora Zora +29.55%
#4 SAFEcoin SAFEcoin +27.83%
#5 Seeker Seeker +26.28%
#6 0G 0G +25.91%
#7 VVS Finance VVS Finance +20.47%
#8 Full Moon Full Moon +17.75%
#9 ADO Protocol ADO Protocol +16.07%
#10 Axelar Axelar +15.77%
Coin of the day
Merlin's Seal BTC Merlin's Seal BTC
Einstellungen
Sprache
DEUTSCH
Währung
USD
Thema
Ever Supreme Bio Technology Co., Ltd Ever Supreme Bio Technology Co., Ltd

Ever Supreme Bio Technology Co., Ltd

6712
Rang in Aktien #13241
This enterprise is dedicated to the investigation, advancement, and creation of... This enterprise is dedicated to the investigation, advancement, and creation of pharmaceutical treatments leveraging human mesenchymal stem cells and immune cells. Its current portfolio features UMC01, a drug candidate undergoing Phase I clinical evaluation for addressing conditions such as myocardial infarction and stroke. Additionally, ADCV01 is progressing through Phase II clinical trials as a potential therapy for aggressive brain tumors. The company also develops CAR001, an innovative chimeric antigen receptor immune cell product, alongside bone-marrow stem cells (BMSC) used in managing chronic stroke, severe osteoarthritis, and spinal cord injuries. Established in 2016, the firm operates from its headquarters in Taichung, Taiwan.
Aktienkurs
$4.99
Marktkapitalisierung
$508.03M
Veränderung (1 Tag)
-2.48%
Veränderung (1 Jahr)
2.10%
Land
TW
Handel Ever Supreme Bio Technology Co., Ltd (6712)

Kategorie

Healthcare
P/S-Verhältnis für Ever Supreme Bio Technology Co., Ltd (6712)
P/S-Verhältnis zum 2026 TTM: 0
Laut den neuesten Finanzberichten und dem Aktienkurs von Ever Supreme Bio Technology Co., Ltd beträgt das aktuelle Kurs-Umsatz-Verhältnis (TTM) 0. Am Ende des Jahres 2026 lag das P/S-Verhältnis bei 0.
P/S-Verlauf für Ever Supreme Bio Technology Co., Ltd von 2026 bis 2026
P/S-Verhältnis zum Jahresende
Jahr P/S-Verhältnis ändert
Nicht genügend Daten für die angegebenen Daten.
P/S-Verhältnis für ähnliche Unternehmen oder Wettbewerber
Unternehmen P/S-Verhältnis P/S-Verhältnis-Differenz Land
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
10.17 -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
10.13 -
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
2.95 -
AU
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
11.28 -
US
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH